Vaccination against herpes zoster is associated with lower risks for heart disease, dementia, and mortality among adults aged 50 years and older.
The researchers found that the weighted incidence rate was 51.90 and 58.41 per 100,000 person-years in individuals initiating SGLT-2 inhibitors and sulfonylureas, respectively.
Replimune Group (($REPL)) announced an update on their ongoing clinical study. Replimune Group is conducting a pivotal Phase 3 clinical study ...
Replimune Group (($REPL)) announced an update on their ongoing clinical study. Replimune Group is conducting a Phase 1B/2 study titled ‘An ...
STI testing: For many women, STIs like chlamydia often have no symptoms but are easily treatable with antibiotics. Left ...
I am a 68-year-old woman who is in relatively good health. My primary exercise is walking my dogs anywhere from 2-5 miles per ...
Omvoh now offers patients a simplified maintenance experience with one monthly injection, replacing the previous two-injection regimen Omvoh single-injection dosing ...
SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the ...
Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) approved a single-injection, once-monthly maintenance regimen (200 mg/2 mL) of Omvoh (mirikizumab-mrkz) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback